• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

55岁以上远视患者两种不同老花眼手术治疗方法的比较:准分子原位角膜磨镶术(Supracor)和有晶体眼人工晶体植入术(Prelex)(老花眼晶状体置换术)

[Comparison of two different surgical treatments of presbyopia for hyperopic patients over 55 years old: Presbylasik (Supracor) and Prelex (presbyopic lens exchange)].

作者信息

Moyal L, Abrieu-Lacaille M, Bonnel S, Sendon D, de Rivoyre B, Berguiga M, Rambaud C, Froussart-Maille F, Rigal-Sastourné J-C

机构信息

Service d'ophtalmologie, hôpital d'instruction des armées-Percy, 101, avenue Henri-Barbusse, 92141 Clamart cedex, France.

Service d'ophtalmologie, hôpital d'instruction des armées-Percy, 101, avenue Henri-Barbusse, 92141 Clamart cedex, France.

出版信息

J Fr Ophtalmol. 2015 Apr;38(4):306-15. doi: 10.1016/j.jfo.2014.10.010. Epub 2015 Apr 1.

DOI:10.1016/j.jfo.2014.10.010
PMID:25842151
Abstract

INTRODUCTION

The management of presbyopic patients is a medical, surgical and economic issue. We wondered which procedure, whether a Presbylasik technique called Regular Supracor or the intraocular surgery of clear lens replacement by a trifocal diffractive lens (presbyopic lens exchange [Prelex]), provided the best results (in visual acuity and satisfaction) for our hyperopic and presbyopic patients between 55 and 70. The aim of this study was to compare the safety and efficacy of the two techniques (at one week and three months) and to assess patients' quality of life.

METHODS

This study is a retrospective monocentric clinical trial conducted between June 2011 and March 2014, on 21 hyperopic presbyopic patients (mean age 60.9 years), in the "hôpital d'instruction des armées-Percy" (Clamart); 13 patients underwent the corneal treatment of Presbylasik (with the Intralase FS60 femtosecond laser [AMO, USA] and the Technolas 217P excimer laser [Technolas Perfect Vision, GmbH] following the Zyoptix Tissue-Saving algorithm adjusted with a nomogram and the Regular Supracor mode), and 8 patients underwent clear lens extraction (Prelex), through bimanual phacoemulsification and implantation of diffractive trifocal intraocular lenses (Finevision Micro F, PhysIOL(*)).

RESULTS

Mean uncorrected binocular distance and near vision visual acuity in the Supracor group were respectively 0.03 (-0.2-0.1) LogMar and 0.23 (0.06-0.36) one week postoperatively and 0.031 (-0.2-0.1) and 0,166 (0.06-0.36) three months postoperatively. In the Prelex group, the mean uncorrected one week binocular VA was 0.025 (0-0.1) for distance vision and 0.165 (0.06-0.18) for near distance and the three months visual acuity was 0 (-0.1-0.1) and 0.105 (0.06-0.18) for distance and near vision. All Prelex patients were spectacle-free at all distances, whereas 4 Supracor patients required spectacles for near vision postoperatively. Seven of 11 patients in the Supracor group and 100% of the Prelex patients were completely satisfied. Both groups experienced halos, but patients reported more halos in the Prelex group (75%). One eye required intraocular lens exchange and four eyes (16.7%) required a new corneal procedure in the Supracor group.

CONCLUSION

Both surgeries are safe and effective modalities in the management of hyperopic and presbyopic patients. However, the Prelex procedure seems to be more appropriate for patients over 55 years of age.

摘要

引言

老花眼患者的治疗是一个医学、手术和经济问题。我们想知道哪种手术,即一种名为常规Supracor的老视激光原位角膜磨镶术(Presbylasik)技术,还是通过三焦点衍射晶状体进行透明晶状体置换的眼内手术(老视晶状体置换术[Prelex]),能为55至70岁的远视和老花眼患者提供最佳效果(在视力和满意度方面)。本研究的目的是比较这两种技术在术后一周和三个月时的安全性和有效性,并评估患者的生活质量。

方法

本研究是一项回顾性单中心临床试验,于2011年6月至2014年3月在“军队教学医院 - 珀西”(克拉马尔)对21例远视老花眼患者(平均年龄60.9岁)进行;13例患者接受了Presbylasik角膜治疗(使用美国AMO公司的Intralase FS60飞秒激光和德国Technolas Perfect Vision公司的Technolas 217P准分子激光,按照Zyoptix组织保存算法并根据列线图和常规Supracor模式进行调整),8例患者接受了透明晶状体摘除术(Prelex),通过双手微切口超声乳化术并植入衍射三焦点人工晶状体(Finevision Micro F,PhysIOL(*))。

结果

Supracor组术后一周的平均未矫正双眼远距离和近距离视力分别为0.03(-0.2 - 0.1)LogMar和0.23(0.06 - 0.36),术后三个月为0.031(-0.2 - 0.1)和0.166(0.06 - 0.36)。在Prelex组中,术后一周的平均未矫正双眼远距离视力为0.025(0 - 0.1),近距离视力为0.165(0.06 - 0.18),术后三个月的远距离和近距离视力分别为0(-0.1 - 0.1)和0.105(0.06 - 0.18)。所有Prelex患者在所有距离均无需佩戴眼镜,而4例Supracor患者术后近距离视力需要佩戴眼镜。Supracor组11例患者中有7例和100%的Prelex患者完全满意。两组均出现眩光,但患者报告Prelex组眩光更多(75%)。Supracor组有一只眼睛需要更换人工晶状体,四只眼睛(16.7%)需要进行新的角膜手术。

结论

两种手术在远视和老花眼患者的治疗中都是安全有效的方式。然而,Prelex手术似乎更适合55岁以上的患者。

相似文献

1
[Comparison of two different surgical treatments of presbyopia for hyperopic patients over 55 years old: Presbylasik (Supracor) and Prelex (presbyopic lens exchange)].55岁以上远视患者两种不同老花眼手术治疗方法的比较:准分子原位角膜磨镶术(Supracor)和有晶体眼人工晶体植入术(Prelex)(老花眼晶状体置换术)
J Fr Ophtalmol. 2015 Apr;38(4):306-15. doi: 10.1016/j.jfo.2014.10.010. Epub 2015 Apr 1.
2
[Management of presbyopic hyperopes by centered presbyLASIK].[通过中心性老视性准分子原位角膜磨镶术治疗老视性远视]
J Fr Ophtalmol. 2014 Nov;37(9):682-8. doi: 10.1016/j.jfo.2014.02.011. Epub 2014 Sep 26.
3
Central PresbyLASIK for Hyperopia and Presbyopia Using Micro-monovision With the Technolas 217P Platform and SUPRACOR Algorithm.使用Technolas 217P平台和SUPRACOR算法的微单眼视技术进行远视和老花眼的中央准分子原位角膜磨镶术
J Refract Surg. 2015 Aug;31(8):540-6. doi: 10.3928/1081597X-20150727-04.
4
PresbyPRK vs presbyLASIK using the SUPRACOR algorithm and micromonovision in presbyopic hyperopic patients: visual and refractive results at 12 months.在老视性远视患者中使用SUPRACOR算法和微单眼视的准分子原位角膜磨镶术(PresbyPRK)与准分子激光原位角膜磨镶术(PresbyLASIK):12个月时的视觉和屈光结果
J Cataract Refract Surg. 2021 Jul 1;47(7):878-885. doi: 10.1097/j.jcrs.0000000000000544.
5
Refractive and Visual Outcomes of SUPRACOR TENEO 317 LASIK for Presbyopia in Hyperopic Eyes: 24-Month Follow-up.远视眼 SUPRACOR TENEO 317 LASIK 矫正老视的屈光和视觉效果:24 个月随访。
J Refract Surg. 2019 Sep 1;35(9):591-598. doi: 10.3928/1081597X-20190815-01.
6
Safety and effectiveness of the SUPRACOR presbyopic LASIK algorithm on hyperopic patients.SUPRACOR老视性准分子原位角膜磨镶术算法对远视患者的安全性和有效性。
Eye Vis (Lond). 2016 Dec 8;3:33. doi: 10.1186/s40662-016-0062-6. eCollection 2016.
7
Supracor hyperopia and presbyopia correction: 6-month results.Supracor远视和老花眼矫正:6个月的结果。
Eur J Ophthalmol. 2014 May-Jun;24(3):325-9. doi: 10.5301/ejo.5000371. Epub 2013 Sep 18.
8
Presbyopia correction with an anterior chamber phakic multifocal intraocular lens.使用前房有晶状体多焦点人工晶状体矫正老花眼。
Ophthalmology. 2005 Aug;112(8):1368-74. doi: 10.1016/j.ophtha.2005.02.029.
9
Corneal approach to hyperopic presbyopia treatment: six-month outcomes of a new multifocal excimer laser in situ keratomileusis procedure.角膜入路治疗远视老视:新的多焦点准分子激光原位角膜磨镶术的六个月结果。
J Cataract Refract Surg. 2013 Aug;39(8):1226-33. doi: 10.1016/j.jcrs.2013.03.016. Epub 2013 Jun 5.
10
Visual outcomes and patient satisfaction after presbyopic lens exchange with a diffractive multifocal intraocular lens.有晶状体眼前房型多焦点人工晶状体置换术后的视觉效果和患者满意度。
J Refract Surg. 2012 Jul;28(7):468-74. doi: 10.3928/1081597X-20120612-01. Epub 2012 Jun 18.

引用本文的文献

1
Supracor Multifocal Corneal Laser-Assisted Keratomileusis Procedure for the Correction of Presbyopia in Hyperopic Eyes.用于矫正远视眼老花眼的Supracor多焦点角膜激光原位角膜磨镶术
J Curr Ophthalmol. 2023 Dec 21;35(2):165-169. doi: 10.4103/joco.joco_2_23. eCollection 2023 Apr-Jun.
2
Clinical outcomes following trifocal diffractive intraocular lens implantation for age-related cataract in China.中国年龄相关性白内障患者三焦点衍射型人工晶状体植入术后的临床结局
Clin Ophthalmol. 2018 Jul 26;12:1317-1324. doi: 10.2147/OPTH.S169215. eCollection 2018.
3
Repeatability of ocular biometry with IOLMaster 700 in subjects with clear lens.
IOLMaster 700在透明晶状体受试者中眼生物测量的可重复性。
Int Ophthalmol. 2017 Oct;37(5):1133-1138. doi: 10.1007/s10792-016-0380-7. Epub 2016 Oct 21.